IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

GARAGIOLA, ISABELLA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.248
NA - Nord America 2.735
AS - Asia 1.082
SA - Sud America 48
AF - Africa 18
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 15
Totale 8.163
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.610
GB - Regno Unito 1.856
CN - Cina 652
DE - Germania 602
SE - Svezia 563
IT - Italia 451
IN - India 129
IE - Irlanda 121
UA - Ucraina 112
CA - Canada 99
RU - Federazione Russa 95
TR - Turchia 93
FR - Francia 90
NL - Olanda 76
EU - Europa 75
KR - Corea 75
FI - Finlandia 73
DK - Danimarca 57
JP - Giappone 35
ES - Italia 32
CO - Colombia 27
HK - Hong Kong 27
NO - Norvegia 21
MX - Messico 20
CH - Svizzera 19
BE - Belgio 17
AU - Australia 15
BR - Brasile 15
IR - Iran 15
SG - Singapore 15
PL - Polonia 14
ID - Indonesia 12
EG - Egitto 10
GR - Grecia 10
RO - Romania 10
VN - Vietnam 8
PT - Portogallo 6
AT - Austria 5
CZ - Repubblica Ceca 4
AE - Emirati Arabi Uniti 3
MD - Moldavia 3
ZA - Sudafrica 3
BQ - ???statistics.table.value.countryCode.BQ??? 2
BZ - Belize 2
CR - Costa Rica 2
IQ - Iraq 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PY - Paraguay 2
QA - Qatar 2
RS - Serbia 2
SC - Seychelles 2
SI - Slovenia 2
TH - Thailandia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BY - Bielorussia 1
CL - Cile 1
GE - Georgia 1
HR - Croazia 1
IS - Islanda 1
JM - Giamaica 1
MA - Marocco 1
ME - Montenegro 1
MK - Macedonia 1
MM - Myanmar 1
MY - Malesia 1
NG - Nigeria 1
OM - Oman 1
PE - Perù 1
PK - Pakistan 1
PR - Porto Rico 1
SA - Arabia Saudita 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 8.226
Salva come PNG Salva come JPEG
Città #
Southend 1.678
Chandler 293
Hanover 275
Seattle 199
Milan 191
Houston 190
Princeton 159
Wilmington 151
Fairfield 133
Ashburn 132
Beijing 128
Dublin 121
Dearborn 104
Jacksonville 82
Woodbridge 81
Ann Arbor 77
Nanjing 75
Redmond 70
Ottawa 69
Mountain View 61
Cambridge 57
Des Moines 53
Bengaluru 49
Frankfurt am Main 49
Sakarya 40
Redwood City 38
Shenyang 36
Saint Petersburg 33
Jinan 32
Boardman 31
Phoenix 31
Serra 29
Changsha 28
Bogotá 27
Andover 26
Hangzhou 25
Somerville 24
Toronto 22
Helsinki 21
Nanchang 21
Margão 20
New York 20
Pisa 20
Bitonto 19
Guangzhou 19
Hebei 19
Kunming 19
London 19
Roxbury 19
Eitensheim 18
Tianjin 18
Centro 17
Hong Kong 17
Grafing 16
Turin 14
Madrid 13
Shanghai 13
Zhengzhou 13
Brussels 12
Medford 12
San Diego 12
Berlin 11
Duncan 11
Munich 11
Silver Spring 11
Jiaxing 10
Rome 10
Athens 9
Fuzhou 9
Taiyuan 9
Zurich 9
Fremont 8
Taizhou 8
Atlanta 7
Bangalore 7
Hefei 7
Ningbo 7
São Paulo 7
Tokyo 7
Amsterdam 6
Barcelona 6
Copenhagen 6
Haikou 6
Lanzhou 6
Leiden 6
Los Angeles 6
Birmingham 5
Columbus 5
Cupertino 5
Istanbul 5
Sydney 5
Warsaw 5
Washington 5
Wuhan 5
Yongin-si 5
Auburn Hills 4
Bondy 4
Boston 4
Bühl 4
Cairo 4
Totale 5.555
Salva come PNG Salva come JPEG
Nome #
A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A 518
Timing and severity of inhibitor development in recombinant versus plasma-derived factor VIII concentrates: a SIPPET analysis 433
Whole-exome sequencing to identify genetic risk variants underlying inhibitor development in severe hemophilia A patients 385
Thrombotic Thrombocytopenic Purpura (TTP) Database 204
The first deletion mutation in the TSP1-6 repeat domain of ADAMTS13 in a family with inherited thrombotic thrombocytopenic purpura 177
Prediction of Factor VIII inhibitor development in the SIPPET cohort by mutational analysis and Factor VIII antigen measurement 175
International Rare Bleeding Disorders Database 174
Genetics of rare bleeding disorders 169
ADAMTS13 mutations and polymorphisms in congenital thrombotic thrombocytopenic purpura 162
Non-invasive tool for foetal sex determination in early gestational age 158
Highly sensitive chemiluminescent method for the detection of cell contamination 156
Database on rare bleeding disorder (RBDS) : phenotype and genotype analysis on 400 affected patients 153
Cytogenetic abnormalities and microsatellite instability in endometrial adenocarcinoma 150
Genetic diagnosis of haemophilia and other inherited bleeding disorders 149
A rare inherited coagulation disorder : combined homozygous factor VII and factor X deficiency 149
Role of von Willebrand factor in the haemostasis 140
Highly sensitive chemiluminescent method for the detection of maternal cell contamination in human cord blood stored for allotransplantation : the experience of the Milano cord blood bank 139
A novel CD46 mutation in a patient with microangiopathy clinically resembling thrombotic thrombocytopenic purpura and normal ADAMTS13 activity 137
Absence of detectable maternal DNA and identification of proviral HIV in the cord blood of two infants who became HIV-infected 136
International Registry of rare bleeding disorders (RBD) 134
Trisomic zygote rescue revealed by DNA polymorphism analysis in confined placental mosaicism 134
Nonsense-mediated mRNA decay in the ADAMTS13 gene caused by a 29-nucleotide deletion 133
The First Deletion Mutation in the TSP1-6 Repeat Domain of ADAMTS13 Leads to a Secretion Defect 132
A recurrent F8 mutation (c.6046C>T) causing hemophilia A in 8% of northern Italian patients : evidence for a founder effect 131
The first deletion mutation in the TSP1-6 repeat domain of ADAMTS13 leads to a secretion defect 126
Detection of maternal DNA in cord blood at birth after elective caesarean section or vaginal delivery 126
ADAMTS-13 Binds Platelets in a Specific, Divalent Cation and Activation Dependent Manner 125
Recurrent mutations identified on LMAN1 and coagulation factors VII, X, XIII genes 125
Characterization of four microsatellites in an Italian population and their application to paternity testing 123
Mutational Repertoire in the SIPPET Cohort and Prediction of FVIII Inhibitor Risk 123
Reproductive care in human immunodeficiency virus serodiscordant couples with haemophilia 122
Losses of heterozygosity in endometrial adenocarcinomas : positive correlations with histopathological parameters 121
The Influence of F8 Mutation and Thrombophilic Genetic Markers on Bleeding Phenotype of Patients Affected with Severe Hemophilia A in the SIPPET Cohort 121
Platelet ADAMTS13 and in vitro expression study of a patient affected by congenital TTP 118
Losses of heterozygosity in oral and oropharyngeal epithelial carcinomas 117
Role of the 2 adenine (g.11293_11294insAA) insertion polymorphism in the 3' untranslated region of the factor VII (FVII) gene : molecular characterization of a patient with severe FVII deficiency 113
Mutations in the MCFD2 gene and a novel mutation in the LMAN1 gene in Indian families with combined deficiency of factor V and VIII 113
Dalla diagnosi di portatrice di emofilia alla diagnosi prenatale 112
The P303T mutation in the human factor VII (FVII) gene alters the conformational state of the enzyme and causes a severe functional deficiency 109
State of the art of rare bleeding disorders database (RBDD) 109
Localization and Function of Platelet ADAMTS-13 108
Severe hemophilia with mild bleeding phenotype : molecular characterization and global coagulation profile 108
Detection of maternal DNA in human cord blood stored for allotransplantation by a highly sensitive chemiluminescent method 107
Pitfalls in molecular diagnosis in a family with severe factor VII (FVII) deficiency-misdiagnosis by direct sequence analysis using a PCR product 106
A novel mutation of alpha2-plasmin inhibitor gene causes an inherited deficiency and a bleeding tendency 106
Prenatal diagnosis and preimplantation genetic diagnosis : novel technologies and state of the art of PGD in different regions of the world 98
Clustered F8 missense mutations cause hemophilia A by combined alteration of splicing and protein biosynthesis and activity 96
Product type and other environmental risk factors for inhibitor development in severe hemophilia A 95
Patients Informative Booklet on the Women with rare bleeding disorders project 92
Residual plasmatic activity of ADAMTS13 correlates with phenotype severity in congenital thrombotic thrombocytopenic purpura 87
Molecular Aggregation of Marketed Recombinant FVIII Products: Biochemical Evidence and Functional Effects 85
Future of coagulation factor replacement therapy 81
Gynecological and obstetrical manifestations of inherited bleeding disorders in women 77
Development of a specific monoclonal antibody to detect male cells expressing the rps4y1 protein 76
Long-term prophylaxis in severe factor VII deficiency 71
Recurrent mutations identified on LMAN1 and coagulation factors VII, X, XIII genes 69
Management of pregnancy and delivery in women with inherited bleeding disorders 68
Performance of a clinical risk prediction model for inhibitor formation in severe haemophilia A 65
Treatment of hemophilia in the near future 60
X Chromosome inactivation: a modifier of factor VIII and IX plasma levels and bleeding phenotype in Haemophilia carriers 58
Pregnancy complications and obstetric care in women with inherited bleeding disorders 55
Nonneutralizing antibodies against factor VIII and risk of inhibitor development in severe hemophilia A 52
Psychological and cognitive factors involved in decision‐making process of haemophilia carriers in reproductive choices 51
Clinical advances in gene therapy updates on clinical trials of gene therapy in haemophilia 48
The past and future of haemophilia : diagnosis, treatments, and its complications 46
Updates on Novel Non-Replacement Drugs for Hemophilia 39
Genetic risk stratification to reduce inhibitor development in the early treatment of hemophilia A : A SIPPET analysis 37
Degradation of two novel congenital TTP ADAMTS13 mutants by the cell proteasome prevents ADAMTS13 secretion 37
Risk factors for inhibitor development in severe hemophilia A 33
Advances in the treatment of bleeding disorders 32
Immune Responses to Plasma-Derived Versus Recombinant FVIII Products 31
The EHA research roadmap: Blood coagulation and hemostatic disorders 23
Genetic variants at the chromosomal region 2q21.3 underlying inhibitor development in patients with severe haemophilia A 23
Molecular study of vascular endothelial growth factor gene in Iranian patients after myocardial infarction 19
Real-life experience in switching to new extended half-life products at European haemophilia centres 17
Post-authorization pharmacovigilance for hemophilia in Europe and the USA: Independence and transparency are keys 15
Knowledge and attitudes toward gene therapy of a cohort of Italian patients with hemophilia 6
Recurrent mutations identified on LMAN1 and coagulation factors VII, X, XIII genes 6
null 3
Totale 8.717
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.150
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.150
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019340 0 0 0 0 0 0 0 0 0 92 151 97
2019/20201.520 202 61 71 119 127 214 129 58 203 194 78 64
2020/2021891 60 92 59 41 103 65 49 51 85 61 178 47
2021/20221.190 73 54 26 105 82 100 86 70 92 133 151 218
2022/20231.316 181 148 93 119 124 234 23 109 126 36 68 55
2023/2024512 35 73 37 39 138 71 29 27 22 41 0 0
Totale 8.717